Clinical trial
Study of TRAVATAN in Subjects With Iris Pigmentation Changes
NCT00047554 · Alcon Research, Industry · Terminated
Key facts
| NCT number | NCT00047554 |
|---|---|
| Title | Study of TRAVATAN in Subjects With Iris Pigmentation Changes |
| Official title | A Five-Year, Multicenter, Commercial Label Safety Study of TRAVATAN® 0.004% in Patients With TRAVATAN-Induced Iris Pigmentation Changes |
| Lead sponsor | Alcon Research, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Open-Angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Travoprost, 0.004% ophthalmic solution |
| Enrollment | 336 |
| Start date | May 1, 2003 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Oct 18, 2002 |
| Last update posted | May 15, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: